Skip to content

Cerebrolysin 60mg

♢ Research use only Spéc. au niveau de la classe ; lots sélectionnés testés par Janoshik

Dosage du contenu Content quantification (Janoshik)Cerebrolysin 60mg · Report #212145 ↗

€28.99

Free standard EU shipping on orders over €200

If a product doesn't match the specification on its published COA, contact us with your batch number: we investigate against the lot's report and replace any product that fails it, at no cost to you.

Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.

Returns policy →
Shipping estimate for EU

3–7 days most of the EU · 10–14 Nordics/Baltics. Dispatched within 1–2 business days. Check destination rates at checkout.

Full shipping information

Cérébrolysine de qualité recherche. Spécification enregistrée : hydrolysat peptidique (extrait de cerveau porcin), ≥85% de peptides ≤10 kDa ; des lots sélectionnés sont testés de manière indépendante. Poudre lyophilisée en flacon de verre scellé. À des fins de recherche uniquement. Ne convient pas à la consommation humaine.

À propos de Cerebrolysin 60mg

Cerebrolysin is a multi-peptide brain-derived neurotrophic preparation consisting of enzymatically treated porcine brain protein. The preparation contains a mixture of low-molecular-weight neuropeptides and free amino acids that cross the blood-brain barrier. It has an unusually long history for a peptide complex and has been studied in the context of neurological injury models including ischemic, traumatic, and vascular insults — and has been characterised since the 1970s. Each vial contains 60mg of the lyophilized preparation.

The active components of Cerebrolysin are not fully defined chemically, which distinguishes it from single-compound neurotrophic peptides. The preparation has demonstrated neurotrophic factor-like activity in cell culture and animal models: it promotes neuronal survival, enhances synaptic plasticity, stimulates neurogenesis, and exhibits neuroprotective effects in various injury models. Preclinical and in-vitro studies have examined its effects on recovery and cognitive parameters in injury and neurodegeneration models, with variable results across study designs. The European Medicines Agency has characterised it within some neurological research contexts.

For research purposes, Cerebrolysin is a useful tool for studying multi-factor neurotrophic support — where the combined effect of multiple small peptides may recapitulate some of the biological activity of endogenous neurotrophic factors (BDNF, NGF, GDNF) more completely than any single defined compound.

Specifications

Parameter Value
Compound Cerebrolysin (porcine brain-derived neuropeptide complex)
Amount per Vial 60mg lyophilized
Composition Low-MW neuropeptides + free amino acids from porcine brain proteins
Format Lyophilized powder
Reconstitution Sterile water or saline
Conservation 2-8°C

Conservation

Store at 2-8°C (refrigerator) as lyophilized powder. Refrigerate after reconstitution. As a biological preparation, avoid freezing and thawing cycles.

What makes Cerebrolysin different from a single neurotrophic peptide?

Single neurotrophic peptides (like BDNF or NGF) target specific receptors. Cerebrolysin contains a mixture of multiple small peptides and amino acids that together mimic aspects of the brain’s complex neurotrophic environment. In research, this can be advantageous when the goal is broad neuroprotection or neurogenesis stimulation rather than receptor-specific pharmacology. The trade-off is that the mixture composition is not fully defined, which limits mechanistic interpretation. Cerebrolysin is better suited for studies where the preparation itself is the research focus, or for generating hypotheses that can then be pursued with defined single compounds.

How does Cerebrolysin penetrate the blood-brain barrier?

Cerebrolysin’s active components are specifically the low-molecular-weight fraction (peptides under approximately 10 kDa) — the preparation is enzymatically processed to ensure these small peptides predominate. Small peptides can cross the blood-brain barrier through passive diffusion (if sufficiently lipophilic), transcytosis, or active transport. The preparation is documented to produce measurable CNS effects after systemic IV or IM administration in preclinical models, indicating at least partial CNS delivery. The full pharmacokinetics of the mixed preparation are complex to characterize precisely.

What are the main research areas for Cerebrolysin?

The most-studied research area for Cerebrolysin is ischemic injury models — preclinical work has examined neurological outcome parameters when administered early in models of ischemic insult. Neurodegeneration models have examined cognitive parameters in some studies but not consistently across designs. Traumatic injury models have been another focus, with preclinical data examining neuroprotection. The research base is heterogeneous in quality, and the compound is characterised differently across regulatory jurisdictions.

Cerebrolysin is supplied for research purposes only. Not for human consumption. Handle in compliance with institutional biosafety guidelines.

La confiance des chercheurs

Pourquoi les chercheurs choisissent CertaPeptides

Qui teste réellement ce produit ?

Les lots sélectionnés sont vérifiés de manière indépendante par Janoshik Analytical (République tchèque) et publiés sur le portail public de Janoshik. Les autres lots sont expédiés avec la spécification de lot du fournisseur. Consultez /coa pour le mur publié.

Voir les COA →

Et si je reçois le mauvais lot ?

Chaque étiquette de flacon porte un code. Recherchez-le sur notre page de vérification : elle affiche ce que CertaPeptides publie pour ce code et, pour un lot retiré, indique que le lot a été retiré et pourquoi. Si le vôtre a été retiré, ou si la recherche du code figurant sur votre étiquette ne donne rien, envoyez-nous ce code par e-mail.

Voir les COA →

D'où le produit est-il expédié ?

Roumanie (UE). Nous sommes CERTALAB SRL, CUI 54169956, immatriculée à la TVA. Sameday pour la Roumanie, GLS pour la plupart des destinations de l'UE, TCE Worldwide pour les autres marchés transfrontaliers de l'UE et hors UE (Royaume-Uni, Suisse). Livraison sous 1–15 jours ouvrés selon la destination — le délai exact est indiqué lors du passage à la caisse.

Détails de l'expédition →

Et en cas de problème ?

Vous disposez d'un droit de rétractation de 14 jours en vertu de l'OUG 34/2014 (droit de la consommation roumain/UE), avec possibilité de recours auprès de l'ANPC et de règlement extrajudiciaire des litiges (SAL). Contactez-nous à support@chinapeptideshop.com.

Politique de retour →

Informations sur le produit

Ce produit est destiné uniquement à des fins de recherche et de développement scientifiques. Il s'agit d'une substance chimique qui ne doit pas être utilisée comme médicament, produit thérapeutique, substance active ou ingrédient dans un quelconque produit destiné à la consommation humaine ou animale. Les chercheurs doivent manipuler ce composé conformément aux directives de biosécurité de leur établissement. À utiliser uniquement dans des environnements de laboratoire correctement équipés, avec un équipement de protection individuelle approprié.

Questions fréquentes

Bibliothèque de recherche

Articles de recherche connexes

Tout voir

Frequently researched together

Combined Price €157.46

View All Products
Parrainez un chercheur

Parlez-en à un collègue chercheur

Offrez 15% de réduction, gagnez 10% sur sa première commande.

Cerebrolysin 60mgResearch use only
Added to cart

Essential cookies keep your cart and account working. Optional content is disabled until you allow it.

Recently viewed products stay only in this browser for up to 30 days. Turning optional personalization off clears that history.

europa.eu/youreurope/garanties

Customer support

Live chat is not connected yet. Please contact our support team by email.

support@chinapeptideshop.com